© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Pfizer Reports Topline Data for Abrysvo Against RSV in Younger High-Risk Adults
August 12, 2024
RSVPreF induced strong neutralizing responses in immunocompromised adults aged 18 years and older in substudy B of the ongoing phase 3 MONET clinical trial.
10 States with the Lowest COVID-19 Vaccination Rates
August 12, 2024
Wyoming, Louisiana, and Oklahoma have the lowest percentage of population with shots in arms based on state population. Is your state among the other 7?
FDA Approves First Intranasal Epinephrine for Emergency Treatment of Allergic Reactions
August 09, 2024
neffy (epinephrine nasal spray) is the first alternative to epinephrine administered by autoinjector or syringe and is comparable in efficacy to the gold standard.
US 2023 Mortality Rate Drops 6% as COVID-19 Slides to 10th Leading Cause: New CDC Data
August 09, 2024
COVID-19 as a cause of death fell from the #4 spot in 2022 to #10 in 2023, which may account for some of the overall decline in the US mortality rate, suggest CDC experts.
Finerenone Phase 3 Data Show Benefit in HFpEF, Promise for New Indication
August 06, 2024
Finerenone treatment achieved a statistically significant reduction in a composite endpoint of CV death and HF events in a population not limited to CKD in T2D, Bayer announced.
HbA1c Time in Range Shows Strong, Consistent Relationship with Dementia in Older Adults with Diabetes
August 05, 2024
New study findings suggest that in older adults stable HbA1c within individualized target ranges over time may help reduce risk of Alzheimer disease and other dementias.
Monitoring Glucocorticoid Therapy in CAH: Timing, Timing, Timing
August 05, 2024
Clinical guideline recommendations for optimal timing to gauge glucocorticoid treatment effects in congenital adrenal hyperplasia require individualization. Here's why.
Treating Congenital Adrenal Hyperplasia: Challenges in the Transition to Adult Care
August 05, 2024
In young adults with congenital adrenal hyperplasia of age to transition to adult care, 25% to 50% are not successful. Here are thoughts on problems and solutions.
Lecanemab Efficacy Continues at 3 Years of Treatment for Early Alzheimer Disease
August 02, 2024
The lecanemab Clarity AD open label extension study returned no new safety signals and data reflect the therapy's disease modifying effects on key biomarkers.
HPV Vaccination Rates, Clinician Recommendations Lag at Public Health Care Facilities
August 02, 2024
HPV series initiation and completion was lower among adolescents seen at public vs private care settings and so was clinician guidance on vaccination in a new study.